CONTRIBUTION OF OATP (ORGANIC ANION-TRANSPORTING POLYPEPTIDE) FAMILY TRANSPORTERS TO THE HEPATIC UPTAKE OF FEXOFENADINE IN HUMANS
暂无分享,去创建一个
Kazuya Maeda | Yuichi Sugiyama | Hiroyuki Kusuhara | K. Maeda | H. Kusuhara | Y. Sugiyama | R. Nishigaki | Kazuho Okudaira | Ryuichiro Nishigaki | Maki Shimizu | Kaori Fuse | K. Okudaira | Maki Shimizu | K. Fuse
[1] Yuichi Sugiyama,et al. Polymorphisms of OATP‐C (SLC21A6) and OAT3 (SLC22A8) genes: Consequences for pravastatin pharmacokinetics , 2003, Clinical pharmacology and therapeutics.
[2] T Nakagawa,et al. A pharmacokinetic analysis program (multi) for microcomputer. , 1981, Journal of pharmacobio-dynamics.
[3] P. Neuvonen,et al. High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1). , 2004, Pharmacogenetics.
[4] Y. Sawada,et al. CITRUS JUICES INHIBIT THE FUNCTION OF HUMAN ORGANIC ANION-TRANSPORTING POLYPEPTIDE OATP-B , 2005, Drug Metabolism and Disposition.
[5] U. Hofmann,et al. Determination of fexofenadine in human plasma and urine by liquid chromatography-mass spectrometry. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[6] P. Meier,et al. The superfamily of organic anion transporting polypeptides. , 2003, Biochimica et biophysica acta.
[7] Bruno Stieger,et al. Enterohepatic bile salt transporters in normal physiology and liver disease. , 2004, Gastroenterology.
[8] D. Keppler,et al. A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[9] U. Hofmann,et al. Fexofenadine pharmacokinetics are associated with a polymorphism of the SLCO1B1 gene (encoding OATP1B1). , 2005, British journal of clinical pharmacology.
[10] A. Brown,et al. Cardiovascular safety of fexofenadine HCl , 1999, Clinical and Experimental Allergy.
[11] Steffen Bauer,et al. Evidence for Inverse Effects of OATP‐C (SLC21A6) *5 and *1b Haplotypes on Pravastatin Kinetics , 2004, Clinical pharmacology and therapeutics.
[12] J. Nezu,et al. Functional Characterization of pH-Sensitive Organic Anion Transporting Polypeptide OATP-B in Human , 2004, Journal of Pharmacology and Experimental Therapeutics.
[13] G R Wilkinson,et al. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[14] J. Nezu,et al. Involvement of Human Organic Anion Transporting Polypeptide OATP-B (SLC21A9) in pH-Dependent Transport across Intestinal Apical Membrane , 2003, Journal of Pharmacology and Experimental Therapeutics.
[15] P. Dawson,et al. Fruit juices inhibit organic anion transporting polypeptide–mediated drug uptake to decrease the oral availability of fexofenadine , 2002, Clinical pharmacology and therapeutics.
[16] D. Keppler,et al. Localization and Genomic Organization of a New Hepatocellular Organic Anion Transporting Polypeptide* , 2000, The Journal of Biological Chemistry.
[17] Y. Sugiyama,et al. Multispecific organic anion transporter is responsible for the biliary excretion of the camptothecin derivative irinotecan and its metabolites in rats. , 1997, The Journal of pharmacology and experimental therapeutics.
[18] Peter J. Meier,et al. Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties , 2004, Pflügers Archiv.
[19] L Landmann,et al. Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. , 2001, Gastroenterology.
[20] B. Haehner‐Daniels,et al. The effect of rifampin administration on the disposition of fexofenadine , 2001, Clinical pharmacology and therapeutics.
[21] D. Keppler,et al. Mutations in the SLCO1B3 gene affecting the substrate specificity of the hepatocellular uptake transporter OATP1B3 (OATP8). , 2004, Pharmacogenetics.
[22] P. Meier,et al. Hepatic uptake of cholecystokinin octapeptide by organic anion-transporting polypeptides OATP4 and OATP8 of rat and human liver , 2001 .
[23] H. Lennernäs,et al. The effect of ketoconazole on the in vivo intestinal permeability of fexofenadine using a regional perfusion technique. , 2003, British journal of clinical pharmacology.
[24] K. Maeda,et al. Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the Hepatic Uptake of Pitavastatin in Humans , 2004, Journal of Pharmacology and Experimental Therapeutics.
[25] P. Meier,et al. Interactions of glycyrrhizin with organic anion transporting polypeptides of rat and human liver. , 2003, Hepatology research : the official journal of the Japan Society of Hepatology.
[26] B. Jarvis,et al. Fexofenadine , 2000, Drugs.